Board of Directors

Jerry Caulder, Ph.D.

Director

Dr. Jerry Caulder is managing director at Finistere Ventures. Dr. Caulder has an unparalleled record in the life sciences industries. During his fifteen years at Monsanto, he held numerous management positions and was responsible for overseeing the company's early venture investments and the launch of new agricultural products globally. In 1984, he became chairman and CEO of Mycogen, a start-up plant sciences company. Under his direction, Mycogen had a successful IPO and was acquired by Dow Agrosciences with a market capitalization of more than $1.2 billion. Since the acquisition, he has held leadership positions in a number of highly successful life science companies including Myelos Pharmaceuticals, a therapeutic drug discovery company focusing on the treatment of diabetic neuropathy, and Advanced Stent Technologies, which focused on the development of a dedicated coronary bifurcation stent. His most recent success was as Chairman of Athenix, Inc., a venture-backed plant sciences company acquired by Bayer Crop Sciences in November 2009 for $400 million. He has been involved in the formation of many local, state and national biotechnology groups and initiatives, including serving as Chairman of BIO, the world's largest biotechnology advocacy and business development organization.

Georges Daou

Chairman

Georges Daou is Chairman of SG Biofuels, Inc. Mr. Daou is an experienced entrepreneur and investor who has founded and developed numerous successful companies. He was the founder of DAOU Systems Inc., a company specialized in designing, building and managing computer networks for healthcare organizations. He built DAOU Systems to more than $125 million in revenue and took the company public in 1997, achieving the fourth best IPO of the year with an increase of valuation to $700 million. Mr. Daou went on to invest in select technology companies and serve as chairman of eAssist.com and digitalorchid.com, where he mentored their CEOs and assisted with significant growth. He completed a BS and an MS degree in Electrical Engineering from University of California, San Diego (UCSD) before beginning his career at WAVETEK as a design engineer.

Kirk Haney

President and CEO

Kirk Haney is President and Chief Executive Officer of SG Biofuels, Inc. Mr. Haney has a successful track record developing sustainable, for profit projects, and extensive experience in both established and start-up companies.

As President of Green Millennium, he raised over $100M in private equity and successfully built and scaled a sustainable forestry company from start-up to over 100 employees. His role consisted of managing all aspects of the business including strategy, operations and finance. Green Millennium's mission is to initiate and manage precious wood reforestation programs in Central America. Thousands of hectares of land that were devastated by years of deforestation have been reclaimed by Green Millennium and returned to their original forested state.

Mr. Haney has held senior and executive management positions for 3Com Corporation, ArrowPoint Communications (acquired by Cisco Systems), Cisco Systems and Green Millennium, Ltd. At ArrowPoint, he held general management responsibility for the Western area. In this role, he built and led an organization that grew revenue from $0 to an $80 million run-rate. This was critical for ArrowPoint's ability to go public in March of 2000 and Cisco's $5.9 billion acquisition. In addition to leading several of Cisco's enterprise and advanced technology organizations, he was instrumental in creating Cisco's global security sales strategy, which resulted in Cisco surpassing $1 billion in security sales. He was also an advisor to Cisco's Corporate Business Development team on various investment and acquisition candidates.

Mr. Haney serves on the board of SG Biofuels, is Chairman of the Board of Cloud Break Advisors, Inc., a Latin American investment firm and he is Chairman of the Board of Green Millennium, Ltd., a sustainable forestry company. He is a member of the board of advisors for the Inter-American Dialogue and serves on the Dean's Leadership Council for the Division of Biological Sciences at the University of California, San Diego. He was named one of the Top 50 People in Bioenergy by Biofuels Digest and is a member of the Young Presidents Organization (YPO).

Anthony Sementelli

Director

Anthony Sementelli is executive vice president, chief financial officer and a member of the leadership team of Flint Hills Resources, LLC. Tony has overall responsibility for the company's accounting, audit, tax, business development, strategic planning, treasury, credit, risk management, legal and information technology activities. Previously, Tony was vice president and chief financial officer of Koch Petroleum Group, which was restructured to form Flint Hills Resources and Koch Supply & Trading in 2002. Tony has held other senior financial positions since joining Koch Industries, Inc. in 1996. Prior to coming to Koch, Tony had financial leadership positions with both Clark Refining and Marketing (now part of Valero) and British Petroleum. Tony was a senior accountant with Ernst & Whinney (now Ernst & Young), focusing on the downstream petroleum industry. Tony graduated summa cum laude from Villanova University, with a bachelor's degree in accountancy in 1985, and is a certified public accountant. Flint Hills Resources is an indirect, wholly owned subsidiary of Koch Industries, Inc. Koch companies have a presence in nearly 60 countries and employ about 70,000 people.

Pratik Shah, Ph.D.

Director

Dr. Pratik Shah is a partner at Thomas, McNerney & Partners. He joined Thomas, McNerney in 2004 and is currently a board member of Auspex Pharmaceuticals, Inc., Cebix Incorporated, CNS Therapeutics, Inc., and Ocera Therapeutics, Inc. Prior to joining Thomas, McNerney, he was the Chief Business Officer and Co-Founder of Kalypsys, Inc., a biopharmaceutical company focused on the discovery and clinical development of new medicines for cancer, inflammation and metabolic disease using its proprietary automation technologies. At Kalypsys, he was responsible for the overall strategy, business development and operations of the company and oversaw raising more than $130 million in equity financings and corporate deals. Before co-founding Kalypsys, he was at McKinsey & Company where he focused on biotechnology and venture capital projects. He was formerly co-founder and VP of Operations at NephRx Corporation, a start-up company focused on the discovery of therapeutic proteins for renal disease. Dr. Shah holds a B.S. in Biological Sciences from the University of California at Irvine and both a Ph.D. in Biochemistry and Molecular Biology and an M.B.A. from the University of Chicago.

Nathan Wood

Director

Nathan Wood is the Vice President of Life Technologies' Genomics Technologies business segment, a position he has held since August 2005. Mr. Wood has more than 22 years of leadership experience in marketing, product development and sales from his work at Invitrogen, QIAGEN and Life Technologies. Prior to joining Life Technologies, he was Director of Sales for QIAGEN, where he led commercial Operation in North America for life science research and molecular diagnostics businesses. Mr. Wood holds a Bachelor of Science degree from Oregon State University and has a number of scientific publications in the scientific area of molecular biology. Mr. Wood has served on the board of visiting advisor for Oregon State University's College of Science and the board of Blue Heron Biotechnologies.

Randy Work

Director

Randy Work is a Managing Director of Kitano Capital LLC, a Dallas-based privately owned, financial asset management company. From 1997 to 2009 he served in various positions for the Lone Star Funds, a global private equity investment fund. From 1998 to 1999, Mr. Work was responsible for establishing and managing the Fund's asset management company in Japan. From 1999 to 2009, he was responsible for the overall investment activity of Lone Star Funds in Japan. During this period, Lone Star invested approximately $6 billion in equity capital into the Japanese market, focusing in distressed debt, real estate and operating companies ranging from a Tokyo-based regional bank to a golf business with over 130 golf courses. Prior to his time at Lone Star, Mr. Work held various positions in the financial/real estate advisory sector at Carbon Mesa Advisors, Kenneth Leventhal & Co. and Robert Charles Lesser & Co. Mr. Work received his BA in International Economics and MBA in Finance from the University of California, Los Angeles.